The OBERON project aimed to develop an integrated testing strategy to identifiy the impact of EDCs on metabolic diseases such as obesity, type II diabetes, or liver steatosis. The project combined knowledge from epidemiological studies, advanced in silico computational models predicting the biological activity of substances from their chemical structure and properties, with experimental methods using in vitro tissue cultures and early developmental stages of fish in vivo. This approach supported by systems biology tools and omics technologies, which mapped changes in gene expression and metabolic pathways imputable to endocrine disruptors (EDCs).

Within the EURION cluster as well as within the project, a gigantic number of results were obtained. That is why the OBERON communication team made an attempt at summarizing and selecting some of those results and showcase them in a series of institutional videos. In these videos, the coordinator, work package leaders and principal investigators of the project are interviewed and share their views and findings according the state of their research.

Dive into the journey with the complete video on YouTube, or follow the series with social media LinkedIn and Instagram.